Gender differences in the prognostic impact of chronic kidney disease in patients with left ventricular systolic dysfunction following ST elevation myocardial infarction treated with primary percutaneous coronary intervention  by Savic, Lidija et al.
Hellenic Journal of Cardiology (2016) 57, 109e115Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.journals .elsevier .com/
hel lenic- journal-of-cardiology/ORIGINAL ARTICLEGender differences in the prognostic impact
of chronic kidney disease in patients with
left ventricular systolic dysfunction
following ST elevation myocardial infarction
treated with primary percutaneous coronary
intervention
Lidija Savic, MD, PhD a,b,*, Igor Mrdovic, MD, PhD a,b,
Milika Asanin, MD, PhD a,b, Sanja Stankovic, PhD c,
Gordana Krljanac, MD a,b, Ratko Lasica, MD, PhD aa Clinical Centre of Serbia, Emergency Hospital, Coronary Care Unit, Belgrade, Serbia
b Clinical Centre of Serbia, Emergency Hospital, Cardiology Clinic, Belgrade, Serbia
c Center for Medical Biochemistry, Emergency Hospital, Clinical Center of Serbia, Belgrade, SerbiaReceived 14 May 2015; accepted 4 December 2015
Available online 6 April 2016KEYWORDS
Gender;
Chronic kidney
disease;
ST-elevation
myocardial infarction* Corresponding author. Lidija Savic, M
E-mail address: lidijasavic@ptt.rs
Peer review under responsibility o
http://dx.doi.org/10.1016/j.hjc.2015
1109-9666/ª 2016 Hellenic Cardiologi
license (http://creativecommons.org/Abstract Background/Aim: Renal function potentially has different prognostic impact in
men and women with acute myocardial infarction. The aim of this study was to evaluate
the prognostic impact of chronic kidney disease (CKD) on five-year all-cause mortality in
men and women with left ventricular systolic dysfunction (LVSD) following ST elevation
myocardial infarction (STEMI).
Method: We included 348 consecutive STEMI patients who were treated with primary percuta-
neous coronary intervention (pPCI) and had a left ventricular ejection fraction < 40%. CKD was
defined as baseline creatinine clearance (CrCl) < 60 ml/min. Patients with cardiogenic shock
at admission were excluded.
Results: Among analyzed patients, 104 patients (29.8%) were women, and 244 patients (70.1%)
were men. Compared with male patients, female patients were older. Females were more
likely to have previous angina and hypertension. CKD was more common in women compared
with men (54.8% vs. 22.5%, p<0.001). Female gender and older age were independentD, PhD, Brace Jerkovic 51/6, 11000Belgrade, Serbia. Tel.:þ381 (0) 63 343 276; fax:þ381 (0) 13 351 651.
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110 L. Savic et al.predictors of CKD. No significant difference in five-year all-cause mortality was between men
and women (27.8% vs. 23.3%, pZ0.370). In a Cox regression model (adjustments were made for
age, Killip class at admission, post-procedural flow TIMI<3, left main stenosis and women with
diabetes), CKD remained an independent predictor of five-year all-cause mortality in men (HR
2.2; 95% CI 1.22e3.3, pZ0.007).
Conclusions: Although pre-terminal CKD was more frequently noted in women, it was an inde-
pendent predictor of five-year mortality exclusively in men. Different prognostic significance
of CKD between sexes indicates that renal function must be considered in the prognosis of
men and women following acute myocardial infarction.
ª 2016 Hellenic Cardiological Society. Publishing services by Elsevier B.V. This is an open ac-
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction
Even in mild forms, chronic kidney disease (CKD) is a well-
known risk factor for adverse cardiovascular outcomes in
patients with ST elevation myocardial infarction (STEMI)
and left ventricular systolic dysfunction (LVSD).1e3 Over the
past several decades, increasing knowledge regarding sex
differences in coronary heart disease has emerged.4 Several
studies suggest that the prevalence of risk factors, patho-
physiology, clinical manifestation and prognosis of coronary
heart disease vary between men and women.4e8 CKD is
more prevalent among women with coronary artery dis-
ease; however, female patients are generally older and
have more comorbidities compared with men.9e11 Certain
studies have shown that CKD has a different prognostic
impact on short-term and mid-term mortality following
STEMI in women and men,9,10 i.e., in patients with angio-
graphically proven coronary disease.11 The results of some
of these studies have shown that CKD is an independent
predictor of mortality following STEMI exclusively in
women.10 In contrast, other studies suggest that CKD is an
independent predictor of mortality in both sexes but ex-
hibits a negative prognostic significance in men.9 Patients
with LSVD following STEMI represent a group with a high risk
of mortality, and this risk is additionally increased by the
presence of CKD.1e3,12 The combined presence of CKD and
LVSD is the most important independent predictor of one-
year overall mortality after pPCI.13 To the best of our
knowledge, the prognostic significance of CKD in women
and men with LVSD after acute myocardial infarction has
not been analyzed to date.
The objective of this study is to evaluate the prognostic
value of renal function on long-term mortality in men and
women with left ventricular systolic dysfunction following
STEMI.
2. Method
2.1. Study population, data collection and
definitions
In the present study, data from the prospective Clinical
Center of Serbia STEMI Register for a subgroup of 348consecutive patients with LVSD hospitalized between
February 2006 and April 2008 were used. The purpose of
the prospective Clinical Center of Serbia STEMI Register
has been published elsewhere.14 In brief, the objective of
the register is to gather complete and representative data
on the management and short- and long-term outcomes of
patients with STEMI undergoing primary PCI at our centre.
The local research ethics committee approved the study
protocol. All consecutive patients with STEMI aged 18 or
older who were admitted to the Coronary Care Unit after
undergoing pPCI at our centre were included in the reg-
ister. For the purpose of this study, patients with cardio-
genic shock at admission were excluded. Coronary
angiography was performed via the femoral approach.
Primary PCI and stenting of the infarct-related artery
(IRA) was performed according to the standard technique.
Aspirin (300 mg) and clopidogrel (600 mg) were adminis-
tered to all eligible patients before pPCI. Selected pa-
tients with visible intracoronary thrombi were also
administered the GP IIb/IIIa receptor inhibitor tirofiban
during pPCI. Flow grades were assessed according to the
Thrombolysis in Myocardial Infarction (TIMI) criteria. After
pPCI, patients were treated according to current
guidelines.
Demographic, baseline clinical, angiographic and pro-
cedural data were collected and analyzed. The baseline
CKD was defined as creatinine clearance (CrCl) < 60 ml/
min/m2 at admission.15 Creatinine clearance was calcu-
lated using the Cockrof-Gault formula:
CrClZ ((140-years)*body weight)/(72*creatinine in mg/dl).
The value was multiplied by 0.85 in females.
Echocardiographic examination was performed within
the first three days after pPCI. The left ventricular
ejection fraction (LVEF) was assessed according to the
biplane Simpson method, in classical two- and four-
chamber apical projections. LVEF<40% was considered
as LVSD. LVEF was absent in 10% of patients. The
missing data were imputed via the single imputation
method.
Patients received follow-up for five years after enrol-
ment. Follow-up data were obtained by scheduled tele-
phone interviews and outpatient visits.
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Continuous variables were expressed as the
mean  standard deviation (SD) if the distribution was
normal or as the median (med) with 25th and 75th quartiles
(IQR) if the distribution was skewed. Categorical variables
were expressed as frequency and percentage. Analysis for
normality of data was performed using the Kolmogorov-
Smirnov test. Baseline differences between groups were
analyzed using the Student t-test (if the distribution was
normal) or the Mann-Whitney test (if the distribution was
skewed) for continuous variables and the Pearson X2 test for
categorical variables. Multivariable logistic regression was
used to define independent predictors of CKD, and the Cox
regression model (backward method, with p < 0.10 for
entrance into the model) was used to identify independent
risk factors for five-year all-cause mortality. The
KaplaneMeier method was used to construct the probability
curves for five-year survival, whereas the difference be-
tween the groups was assessed using the Log-Rank test.
SPSS statistical software version 14.0 was applied (SPSS
Inc., Chicago, IL).
3. Results
Out of a total of 348 patients, 104 (29.8%) were women,
and 244 (70.2%) were men. Compared with men, women
were older and had a higher prevalence of previous
angina and hypertension, but they were less likely to be
smokers. Regarding renal function, 54.8% of women and
22.5% of men had CrCl<60 ml/min/m2. The demographic
characteristics, risk factors, previous cardiovascular
diseases or procedures, characteristics on admission,
renal function, angiographic, procedural characteristics
and therapy at discharge in relation to gender are pre-
sented in Table 1.
The female gender and (older) age were independent
predictors of CKD [female gender OR 4.11 (95% CI
2.11e7.97), p<0.001; age (years) OR 1.21 (95% CI
1.16e1.26), p<0.001].
During hospitalization, a lethal outcome was registered
in 18 (17.3%) women and 39 (15.9%) men (pZ 0.760). A
lethal outcome within the first 30 days was registered in 20
(19.3%) women and 43 (17.6%) men (pZ0.721). During the
five-year follow-up, a lethal outcome was registered in 29
(27.8%) women and 57 (23.3%) men (pZ0.370).
Deteriorating renal function was associated with
increasing five-year mortality in both men and women, as
presented in Fig. 1.
Table 2 presents the unadjusted and adjusted hazard
ratios (95% confidence interval) for all-cause mortality
during follow-up (Cox regression model) according to
gender. In the Cox regression model for five-year all-cause
mortality, adjustments were made for the following vari-
ables: age (years), heart failure at admission, diabetes,
three-vessel disease and postprocedural TIMI flow grade
<3.
After adjusting variables defined in the univariate anal-
ysis as predictors of mortality, CKD remained an indepen-
dent predictor of all-cause mortality during a five-year
follow-up in men but not in women, as shown in Table 2.4. Discussion
The results of the present study confirmed that patients
with LVSD following STEMI who had a reduced CrCl had an
increased five-year mortality rate compared with patients
with preserved kidney function. In both men and woman,
the lower the CrCl, the higher the mortality rate. No sta-
tistically significant difference in five-year mortality be-
tween men and women was noted. CKD was more often
noted in women. CKD was a strong predictor of five-year
mortality in both sexes in the univariate analysis. However,
after multivariate adjustment, CKD remained an indepen-
dent predictor of mortality exclusively in men.
Differences in survival between women and men with
acute myocardial infarction have been reported in various
studies.16e18 In other studies, the differences in survival
disappear after adjustments for age, comorbidity, and
other differences in baseline characteristics between
sexes.8,19e22 In addition, data demonstrate a difference in
survival between men and women upon myocardial infarc-
tion during short-term follow-up. In contrast, during long-
term follow-up (greater than one year), the survival in
women and men is approximately identical.19,23 Although
no difference was registered in the present study regarding
short-term and long-term mortality between men and
women, the independent predictors were different, i.e.,
they had a different prognostic significance.
To date, two studies have analyzed the prognostic
impact of CKD on mortality in men and women with STEMI
who underwent primary PCI,9,10 but no studies are avail-
able comparing the prognostic impact of CKD in men and
women with LVSD following STEMI. The study by Damman
et al. that analyzed approximately 2,000 patients reported
that decreased kidney function is associated with increased
30-day mortality and long-term mortality (3 years) in men
and women treated with pPCI.9 Similar to the present
study, baseline kidney function was assessed using the
Cockroft-Gault formula.9 This study reported that women
were older, more frequently suffered from hypertension,
and smoked less frequently smokers. In addition, the pa-
rameters of kidney function (eGFR) were reduced in
women compared with men, and these findings are
consistent with our findings.9 The value of estimated
glomerular filtration (eGFR) <60 ml/min was a strong in-
dependent predictor of mortality in both women and men;
however, an increased hazard ratio for mortality at 30-day
and three-year follow-up was registered in men.9 This
difference in the independent and negative influence of
reduced eGFR values remained even after adjustment for
other independent mortality predictors (mortality pre-
dictors from the TIMI score and by adding biomarkers NT-
pro BNP, glucose, and cardiogenic shock).9 In the present
study, the independent and negative predictive influence
of CKD in women disappeared after adjusting for variables
that were predictors of five-year mortality defined in the
univariate analysis. In contrast to the present study, a
study by Lawesson et al. found that reducing eGFR every
10 ml/min was an independent predictor of mortality and
major adverse cardiovascular events (MACE) during one-
year follow-up exclusively in women treated with pPCI.10
This study also observed CKD more frequently in
Table 1 Baseline characteristics and therapy at discharge of the study patients according to gender.
Characteristics Women (NZ104) Men (NZ244) p-value
Age, years med (IQR) 67.5 (65, 70) 57 (51, 67) <0.001
Previous MI, n (%) 13 (12.5) 56 (22.9) 0.025
Previous AP, n (%) 17 (16.3) 11 (4.5) <0.001
Previous PCI, n (%) 1 (0.9) 12 (4.9) 0.055
Previous stroke, n (%) 6 (5.7) 17 (6.9) 0.681
Diabetes, n (%) 29 (27.8) 55 (22.5) 0.286
Hypertension, n (%) 80 (76.9) 154 (63.1) 0.012
HLP, n (%) 65 (62.5) 145 (59.4) 0.592
Smoking, n (%) 36 (34.6) 135 (55.3) <0.001
Pain duration, hours med (IQR) 4.75 (2.5, 7.0) 3 (2, 5) 0.529
HF at admission, n (%) 41 (39.4) 77 (31.5) 0.156
Systolic BP (mmHg) at admission, XSD 133.829.13 129.735 0.257
HR at admission, XSD 82.718.15 80.821.8 0.357
Door to balloon time, minutes, med (IQR) 120 (86, 170) 125 (85, 180) 0.900
three-vessel disease, n (%) 33 (31.7) 92 (37.7) 0.288
Pre-procedural flow TIMI 0, n (%) 67 (64.4) 158 (64.7) 0.321
LM stenosis, n (%) 9 (8.7) 22 (9) 0.954
IIb/IIIa blockers, n (%) 51 (49) 135 (55.3) 0.321
Stent implantation, n (%) 94 (90.4) 221 (90.6) 0.956
Postprocedural flow TIMI<3, n (%) 14 (13.5) 24 (9.8) 0.351
Acute stent thrombosis, n (%) 1 (0.9) 4 (1.7) 0.193
LVEF (%), XSD 36.45.65 35.46.54 0.148
CKmax, med (IQR) 2406 (1272,3565) 2890 (1506, 4927) <0.001
Troponin I (mg/L) med (IQR) 15 (12.8, 17,6) 25 (9.5, 19.6) <0.001
Creatinine mmol/L med (IQR) 67.5 (57, 73) 97 (86, 105) <0.001
CrCl ml/min med (IQR) 65 (57, 73) 84 (68, 106) <0.001
CrCl>60 ml/min 47 (45.1) 189 (77.4) <0.001
CrCl 45e60 ml/min 34 (32.8) 35 (14.4) <0.001
CrCl<45 ml/min 23 (22.1) 20 (8.2) <0.001
Therapy at discharge
Aspirin, n (%) 101 (97.6) 240 (98.7) 0.609
Clopidogrel, n (%) 102 (98) 238 (97.5) 0.990
Beta blockers, n (%) 77 (74) 195 (79.9) 0.061
ACE inhibitors, n (%) 74 (71.1) 175 (71.7) 0.953
Statins, n (%) 77 (74.1) 186 (76.2) 0.660
Diuretics, n (%) 60 (57.6) 142 (58.2) 0.597
Antiarrhythmics, n (%) 7 (6.7) 11 (4.6) 0.376
Digitalis, n (%) 3 (2.8) 5 (2.4) 0.622
Warfarin, n (%) 6 (5.7) 22 (9.1) 0.316
APZangina pectoris; HLPZhyperlipidaemia; MIZmyocardial infarction; HFZheart failure; BPZarterial blood pressure; HRZheart rate;
LMZleft main coronary artery; CKZcreatinine kinase; CrClZcreatinine clearance; LVEFZ left ventricular ejection fraction; ACE-
Zangiotensin converting enzyme.
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increased frequency of hypertension and/or diabetes
mellitus. However, even after adjusting these variables,
the female sex remained an independent predictor of CKD;
females exhibited a 5-fold increased risk of CKD compared
with males.10
The differences in the prognostic impact of CKD be-
tween women and men were reported in other studies
analyzing patients with coronary disease but not patients
with a decreased ejection fraction. A smaller study
including patients who suffered from acute coronary syn-
drome revealed that an elevated creatinine value at
admission to hospital was an independent predictor of long-
term mortality in women but not in men.24 A study by Chen
et al. analyzing consecutive patients referred forcoronagraphy (data from the Appropriateness of Coronary
Revascularization (ACRE) Study) reported that mild and
moderate CKD were stronger independent predictors of
long-term mortality in women compared with men.11
The difference in the prognostic significance of CKD in
women and men with coronary disease has not been
completely explained; the different prevalence of risk
factors for coronary disease, CKD and mortality were noted
as the possible reason for this being the case.9,10,20,25
Women with coronary disease are generally older and are
more prone to CKD, and the value of CrCl decreases with
age. In addition, the simultaneous presence of multiple risk
factors for coronary disease, CKD, and mortality (e.g.,
diabetes mellitus, hypertension, etc.) is thought to be more
common in women.9,20 When the characteristics of women
Figure 1 KaplaneMeier curves estimating the probability of five-year mortality according to gender and renal function.
Table 2 Unadjusted and adjusted hazard ratios (95% confidence interval) for five-year all-cause mortality according to
gender.
Variable Women
HR (95% CI)
p-value Men
HR (95% CI)
p-value
Unadjusted HR
CrCl<60 ml/min 2.4 (1.1e5.4) 0.037 3.0 (1.8e5.1) <0.001
Adjusted HR
CrCl<60 ml/min 1.4 (0.6e3.7) 0.495 2.2 (1.2e3.3) 0.007
CrCl 45e60 ml/min 1.1 (0.4e2.7) 0.912 1.8 (0.9e3.7) 0.054
CrCl < 45 ml/min 2.1 (0.8e4.8) 0.817 2.8 (1.4e4.9) <0.001
Age (years) 1.1 (1.0e1.2) <0.001 1.01 (1.0e1.06) 0.006
Postprocedural flow TIMI<3 4.1 (1.8e9.2) 0.001 2.6 (1.4e4.9) 0.004
HF at admission 2.2 (1.1e4.8) 0.040 2.9 (1.7e5.1) <0.001
Three-vessel disease ns 1.7 (1.1e2.9) 0.048
CrClZcreatinine clearance; HFZheart failure; ns = non significant.
Primary percutaneous coronary intervention 113and men with intact kidney function (CrCl>60 ml/min)
were compared, men with CrCl>60 ml/min generally
exhibited more favourable baseline characteristics
compared with women with CrCl >60 ml/min.9,10 However,
even after multivariate adjustment of most of the known
variables that may be associated with an increased risk of
CKD, the female sex continues to be an independent pre-
dictor of CKD.10 Renal dysfunction is associated with
anaemia, endothelial dysfunction, elevated homocysteine
levels, procoagulation status, systemic inflammation, and
hyperparathyroidism. However, these factors are typically
not routinely noted in everyday clinical practice or studies,
including the present one. The difference between these
characteristics in men and women cannot be excluded, and
the differences could be the reason for the different
prognostic impact of CKD.4,9e11 Finally, some authors sug-
gest that the difference in the prognostic impact of CKD
between the sexes could be caused by differences in
treatment for women and men with myocardial infarction,
which primarily involve less frequent application of therapy
with a favourable influence on survival, e.g., ACE inhibitors
and beta blockers.4,10,19 The present study did not registera difference in prescribed therapy between women and
men at the time of hospital release or during follow up, so
this factor cannot be deemed the cause of the different
prognostic impact of CKD. However, our study was not
designed to analyze the influence of therapy on survival.
Nevertheless, gender differences in the prognostic impact
of CKD in men and women with coronary artery disease
require further investigation.10
5. Conclusion
In this single-centre study, no gender differences in five-
year all-cause mortality were noted in patients with left
ventricular systolic dysfunction following STEMI. Although
pre-terminal CKD was more frequently noted in women, it
was exclusively an independent predictor of five-year
mortality in men. This result requires confirmation using a
larger number of patients with more events. The different
prognostic significance of CKD between sexes indicates that
renal function must be considered in the prognosis of men
and women following acute myocardial infarction.
114 L. Savic et al.6. Study limitations
This is an observational prospective study, but it included
consecutive patients, thus limiting possible selection bias.
Data from follow-up echocardiographic examinations ob-
tained while monitoring of patients with LVSD are not
available to assess whether a certain degree of recovery of
myocardium contractility occurred. On the other hand, the
coincidence of CKD potentially influenced the deterioration
of systolic function and left ventricle remodelling.26 Renal
function was not evaluated during follow-up. However,
during the five-year follow-up, terminal renal insufficiency
did not occur, and none of the patients started haemo-
dialysis. Renal function was assessed using the Cockroft-
Gault formula,27,28 which also has limitations.
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